Addition of fibrinogen to human umbilical vein endothelial cells in culture resulted in release of von Willebrand factor (vWf) from Weibel-Palade bodies that was temporally related to formation of fibrin in the medium. Whereas no release occurred before gelation, the formation of fibrin was associated with disappearance of Weibel-Palade bodies and development of extracellular patches of immunofluorescence typical of vWf release. Release also occurred within 10 min of exposure to preformed fibrin but did not occur after exposure to washed red cells, clot liquor, or structurally different fibrin prepared with reptilase. Metabolically labeled vWf was immunopurified from the medium after release by fibrin and shown to consist of highly processed protein lacking pro-vWf subunits. The contribution of residual thrombin to release stimulated by fibrin was minimized by preparing fibrin clots with nonstimulatory concentrations of thrombin and by inhibiting residual thrombin with hirudin or heating.
The initial hemostatic response to vascular injury requires vWf-mediated platelet adhesion and aggregation, and, therefore, the release of high molecular mass vWf multimers from endothelial cells could facilitate formation of a hemostatic plug. Be 
Methods
Cell culture. Human umbilical vein endothelial cells were isolated and cultured by a modification of the methods described by Gimbrone and colleagues (13, 21) . Cells obtained from 5 3.7% formaldehyde and permeabilized when desired with 0.5% Triton X-100 in the same buffer. Indirect immunofluorescent staining of endothelial cells for vWf followed the procedure described previously (13) . The primary antibody, rabbit anti-human vWf, was prepared as described (I13, 22) (27) .
Blood and purified plasma proteins. After obtaining consent, unanticoagulated whole blood was obtained from healthy volunteers by venipuncture. To obtain red blood cells, 1 ml of whole blood was diluted in 15 ml of Hanks' buffer and centrifuged at 2300 g for 10 min at 250C.
The supernatant was discarded and the washing repeated six times. Purified Factor XIII (Behringwerke A. G., Marburg, FRG) was dissolved in water to a concentration of 1 U/ml and activated for 30 min with 1 U/ml thrombin in 10 mM CaCI2 at 370C, and the thrombin inhibited with a 10-fold excess of hirudin. Purified tissue plasminogen activator was a gift from Desire Collen (Leuven, Belgium).
Results
Adding fibrinogen to cultures of human umbilical vein endothelial cells resulted in the slow formation of fibrin clot over the cells. Coverslips were removed and cells stained for vWf using indirect imnmunofluorescence with and without permeabilization before clot formation (10 min) and after the cells became covered with clot (3 h) . Control cells to which no fibrinogen was added were processed in parallel. Cells exposed to fibrinogen for 10 min were indistinguishable from controls with vWf in the perinuclear region (endoplasmic reticulum and Golgi apparatus) and in Weibel-Palade bodies (Fig. 1, a and b ) and little vWf was associated with the external cell surface (Fig. 1, d and e). Only 12% of cells at this time showed any release, which was comparable to that in control cultures. In contrast, at 3 h (after clot formation) 90% ofcells had lost their Weibel-Palade bodies ( Fig.   1 c) and showed irregular patches of surface staining (Fig. 1, c andf). Formation of fibrin over the cells was not necessary for release, because fibrin clots prepared separately and transferred onto the cells caused release within 10 min (see below). Cells in the same dish but not directly underlying the fibrin clot showed no release, which suggested that cell-fibrin contact and not a diffusable substance was necessary for release.
A possible explanation for these results is that the formation of fibrin potentiated the effects ofthrombin present in the culture medium at concentrations insufficient to cause release by itself. Therefore, the effects ofthrombin and thrombin inhibitors were examined in the system. Thrombin at concentrations from 1 X 10-to 1.2 U/ml in culture medium was added to endothelial cells and the proportion of cells showing any vWf release at 10 min determined (Fig. 2) . No significant release occurred at concentrations of 5 X 10-3 U/ml and below, while at higher concentrations progressively more release was seen up to a concentration of 0.1 U/ml, which caused maximum release.
To minimize their thrombin content, fibrin clots were prepared from fibrinogen using a thrombin concentration of 5 X 10-3 U/ml, the minimum concentration required for adequate clotting. When placed on cultured endothelial cells in culture medium, these clots stimulated release of vWf within 10 min (Fig. 3 b, Table I ). To further reduce the effect of thrombin, clots made in the same way were incubated in 0.25 U/ml hirudin, a thrombin inhibitor, and hirudin was also included at the same concentration in the culture medium to which the preformed clots were added. Although the thrombin content of the clots after hirudin incubation had decreased by 73%, from 1.5 X l0-3 to 4 X 10-4 U, they still stimulated complete release of vWf within 10 min. (Fig. 3 e, Table I ). Hirudin by itselfin the culture medium at 0.25 U/ml had no effect on vWf release ( Fig. 3 d, Table I ), but this concentration was sufficient to completely inhibit release stimulated by 0.1 U/ml of thrombin ( Fig. 3 f Table I ).
Heat denaturation was also used to inactivate thrombin. Thrombin in solution showed a progressive temperature-dependent decrease in activity after incubation at temperatures above 37°C, with no residual activity by chromogenic assay at temperatures of 70°C or above (Fig. 4 a) . The decrease in chromogenic activity was paralleled by a decrease in the ability of the thrombin to stimulate vWf release from endothelial cells (Fig. 4 b) . On the other hand, heated fibrin clots showed no decrease in ability to stimulate vWf release from endothelial cells despite incubation at temperatures of up to 100°C for 2 h (Fig. 4 b) (Table II) , indicating that fibrinopeptides A and B, which are cleaved by thrombin during fibrin formation, were ineffective stimulants. Tissue plasminogen activator (100 ng/ml) and activated Factor XIII (1 U/ml) did not stimulate release above background (not shown). In addition, washed red cells did not cause release (Table  II) , suggesting that interaction with a foreign surface is not a sufficient release stimulus. Addition to endothelial cells of fresh, unanticoagulated whole blood (2 ml/dish) resulted in a rapid formation of a clot within 10 min causing release of vWf (Table  II) with no major change in endothelial cell shape or adherence. Reptilase, an enzyme derived from the venom of Bothrops atrox, cleaves only fibrinopeptide A from fibrinogen resulting in a structurally different clot with minimal Factor XIII cross-linking (Fig. 6 ). Clots formed with reptilase failed to stimulate release from the Weibel-Palade bodies (Table II) , indicating that the specific fibrin structure resulting from thrombin action was necessary for stimulation. Figure 4 . Effect of heating on thrombin activity and on the ability of thrombin or fibrin to induce vWf release from endothelial cells. (A) Thrombin (0.1 U/ml in Hanks' buffer) was incubated for 2 h at temperatures from 40 to 100IC after which the solutions were equilibrated to 250C and assayed for activity using a chromogenic substrate. Each point represents the average of two separate determinations. (B) Fibrin clots were prepared in Hanks' buffer using a thrombin concentration of 5 X 10-3 U/ml. The washed clots and a solution of thrombin (0.1 U/ml in Hanks' buffer) were both incubated for 2 h at temperatures from 40 to 1000C, equilibrated to 370C, and then placed over 80% confluent endothelial cells for 10 min. The cells were then fixed, permeabilized, stained by immunofluorescence for vWf, and the percentage of cells showing vWf release determined. All points represent the average of two experiments. Open squares, data points for thrombin. Open circles, data points for fibrin stimulation.
constitutively (19) . The vWf released by fibrin, similar to A23 187-released vWf ( 19) , did not contain the pro-vWf subunit (Fig. 5 ), indicating that it also originated from the Weibel-Palade bodies. Fibrin did not cause cell lysis because no pro-vWf subunits with immature carbohydrate that comprises one-half the cellular pool of vWf (18) was detected in the released protein (Fig. 5) . The Mr 180,000 subunit fragment seen in the fibrinreleased vWf (Fig. 3) is of similar size to a major fragment of M, 176,000 found in cryoprecipitate (22) or normal human plasma (30). It was not seen after release with A23187 (19) or after incubation of the A23 187 releasate with fibrin, suggesting that fibrin exposure led to expression of an endothelial cell protease that partially degraded the released vWf. Thrombin has been shown to bind to endothelial cells (31) but its activity as secretagogue for vWf is related to its proteolytic activity rather than occupation of a specific receptor (15, 16) and is mediated by phospholipid methylation (32 (15) (Fig. 2) and confirm that the thrombin active site is necessary for release because hirudin treatment was inhibitory (Fig. 3 , Table I ) and the chromogenic activity of heat-treated thrombin was closely paralleled by its ability to release vWf (Fig. 4) . However, several findings indicate that the release seen after exposure to fibrin was not due to thrombin activity. First, addition of fibrinogen to endothelial cell cultures without altering thrombin concentration caused release, and the release was temporally correlated with fibrin gelation (Fig. 1) . Second, rapid release occurred after exposure to preformed fibrin clots made at thrombin concentrations below that required for stimulation (Fig. 3) . Third, release was not inhibited by hirudin, while hirudin inhibited release by higher concentrations of thrombin in solution (Fig. 3) , and finally, heating of fibrin did not prevent release, while this completely abolished the activity of thrombin (Fig. 4) . We do not exclude the possibility that thrombin at concentrations much lower than those that cause release free in solution was present in the treated clots. While this thrombin may have contributed to the release process, the primary inducer in these experiments appeared to be fibrin.
Fibrinogen has previously been shown to interact specifically with endothelial cells. Dejana et al. (33) demonstrated that fibrinogen bound to endothelial cells in a saturable and reversible (35) showed that fibrinogen fragment D caused disorganization of confluent endothelial monolayers with cellular retraction and projection of pseudopodia. Endothelial cells contain membrane proteins with similar electrophoretic mobility and immunological reactivity to the platelet membrane glycoproteins IIB and IIIA (36, 37) , which function as the platelet fibrinogen receptor during aggregation (38, 39) . In our experiments, exposure of endothelial cells to fibrinogen in the absence of clotting caused no release, indicating that occupancy of an endothelial cell membrane fibrinogen receptor was not a sufficient release stimulus. It is also unlikely that crosslinking ofthe fibrinogen receptors during fibrin formation caused the observed release, because fibrin formed with reptilase should also possess multiple binding sites but was ineffective (Table II) .
Endothelial cells secrete several proteins involved in different aspects of the hemostatic response including vWf, which promotes platelet adhesion and aggregation (8, 12) , protein S, which potentiates the anticoagulant action of protein C (40, 41) , and both plasminogen activators (42, 43) and plasminogen activator inhibitor (44) , which together regulate activation of fibrinolysis. Therefore, control of endothelial cell synthesis and secretion of these proteins is of central importance in coordinating the local hemostatic response to vessel injury. The effects ofthrombin on endothelial cells are multiple and include induction ofboth procoagulant activities, for example in increasing vWf release (15) , and profibrinolytic activity such as increasing synthesis and secretion of plasminogen activator (43) . However, these two disparate effects are temporally separated so that the release of vWf occurs rapidly (16, 19, Fig. 3 ), whereas the increased secretion of plasminogen activator occurs after several hours (43) , thus promoting delayed clot dissolution and removing fibrin from the endothelial cell surface. 
